APPLICATION
ANDA209308
TYPE
ANDA
ORIGINAL APPROVAL
2018-10-22
LATEST ACTION
2023-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
CLOBAZAMDiscontinued
CLOBAZAM 20MG · TABLET · ORAL
CLOBAZAMDiscontinued
CLOBAZAM 5MG · TABLET · ORAL
CLOBAZAMDiscontinued
CLOBAZAM 10MG · TABLET · ORAL
Approval history
2023-05-01Labeling · Supplement 9 · standardAP
2021-09-28Labeling · Supplement 6 · standardAP
2018-10-22UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.